Ishwarya Mamidi
NPI 1871172742 · Student in an Organized Health Care Education/Training Program · New Orleans, LA
Enrolled with Medicare as Order and Referring Only - Otolaryngology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Ishwarya Mamidi is a Student in an Organized Health Care Education/Training Program provider in New Orleans, LA (NPI 1871172742).
Provider details
- NPI number
- 1871172742
- Entity type
- Individual
- Primary specialty
- Student in an Organized Health Care Education/Training ProgramStudent, Health Care
- Sex
- Female
- Sole proprietor
- No
Specialties & taxonomies
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
5 yrs in NPPES registry
- Profile completeness33% of score
83% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 26 | 24 |
| Doxycycline Monohydrate | 13 | 13 |
| Ondansetronbrand: Ondansetron Odt | 12 | 12 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 11 | 11 |
| Famotidine | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$361 across 8 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2021-04-06
- Last updated
- 2021-04-06
- Certified
- 2021-04-06
Frequently asked questions
- What is Ishwarya Mamidi's NPI number?
- Ishwarya Mamidi's National Provider Identifier (NPI) is 1871172742, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Ishwarya Mamidi's specialty?
- Ishwarya Mamidi is listed in the NPPES registry with a primary specialty of Student in an Organized Health Care Education/Training Program (Student, Health Care).
- Where is Ishwarya Mamidi located?
- Ishwarya Mamidi's practice location on file with NPPES is 533 Bolivar St Ste 566, New Orleans, LA 70112-1349.
- What is Ishwarya Mamidi's phone number?
- The practice phone number listed in the NPPES registry for Ishwarya Mamidi is (908) 745-1253.
- Does Ishwarya Mamidi accept Medicare?
- Ishwarya Mamidi is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Ishwarya Mamidi's NPI active?
- Yes — Ishwarya Mamidi's NPI (1871172742) is active in the NPPES registry as of the last update on 2021-04-06.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.